Angela Luttick

10/585 Blackburn Road
Notting Hill, VIC 3168, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

N-chlorotaurine is highly active against respiratory viruses including SARS-CoV-2 (COVID-19) in vitro.

N-chlorotaurine is highly active against respiratory viruses including SARS-CoV-2 (COVID-19) in vitro.

Journal: Emerging microbes & infections

Published: April 14, 2022

Validation of a single-step, single-tube reverse transcription loop-mediated isothermal amplification assay for rapid detection of SARS-CoV-2 RNA.

Validation of a single-step, single-tube reverse transcription loop-mediated isothermal amplification assay for rapid detection of SARS-CoV-2 RNA.

Journal: Journal of medical microbiology

Published: August 07, 2020

Sars-CoV-2 (COVID-19) inactivation capability of copper-coated touch surface fabricated by cold-spray technology.

Sars-CoV-2 (COVID-19) inactivation capability of copper-coated touch surface fabricated by cold-spray technology.

Journal: Manufacturing letters

Published: May 13, 2020

Prodrugs of imidazotriazine and pyrrolotriazine C-nucleosides can increase anti-HCV activity and enhance nucleotide triphosphate concentrations in vitro.

Prodrugs of imidazotriazine and pyrrolotriazine C-nucleosides can increase anti-HCV activity and enhance nucleotide triphosphate concentrations in vitro.

Journal: Bioorganic & medicinal chemistry letters

Published: October 07, 2014

The discovery of 1,2,3,9b-tetrahydro-5H-imidazo[2,1-a]isoindol-5-ones as a new class of respiratory syncytial virus (RSV) fusion inhibitors. Part 1.

The discovery of 1,2,3,9b-tetrahydro-5H-imidazo[2,1-a]isoindol-5-ones as a new class of respiratory syncytial virus (RSV) fusion inhibitors. Part 1.

Journal: Bioorganic & medicinal chemistry letters

Published: September 24, 2014

1,2,3,9b-Tetrahydro-5H-imidazo[2,1-a]isoindol-5-ones as a new class of respiratory syncytial virus (RSV) fusion inhibitors. Part 2: identification of BTA9881 as a preclinical candidate.

1,2,3,9b-Tetrahydro-5H-imidazo[2,1-a]isoindol-5-ones as a new class of respiratory syncytial virus (RSV) fusion inhibitors. Part 2: identification of BTA9881 as a preclinical candidate.

Journal: Bioorganic & medicinal chemistry letters

Published: September 24, 2014

Derivatives of imidazotriazine and pyrrolotriazine C-nucleosides as potential new anti-HCV agents.

Derivatives of imidazotriazine and pyrrolotriazine C-nucleosides as potential new anti-HCV agents.

Journal: Bioorganic & medicinal chemistry letters

Published: July 08, 2014

Characterization of drug-resistant influenza virus A(H1N1) and A(H3N2) variants selected in vitro with laninamivir.

Characterization of drug-resistant influenza virus A(H1N1) and A(H3N2) variants selected in vitro with laninamivir.

Journal: Antimicrobial agents and chemotherapy

Published: June 25, 2014

A zanamivir dimer with prophylactic and enhanced therapeutic activity against influenza viruses.

A zanamivir dimer with prophylactic and enhanced therapeutic activity against influenza viruses.

Journal: The Journal of antimicrobial chemotherapy

Published: April 30, 2014

Discovery and Synthesis of C-Nucleosides as Potential New Anti-HCV Agents.

Discovery and Synthesis of C-Nucleosides as Potential New Anti-HCV Agents.

Journal: ACS medicinal chemistry letters

Published: February 20, 2014

Methods to determine mechanism of action of anti-influenza inhibitors.

Methods to determine mechanism of action of anti-influenza inhibitors.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: July 04, 2013

An Orally Available 3-Ethoxybenzisoxazole Capsid Binder with Clinical Activity against Human Rhinovirus.

An Orally Available 3-Ethoxybenzisoxazole Capsid Binder with Clinical Activity against Human Rhinovirus.

Journal: ACS medicinal chemistry letters

Published: December 14, 2011

Showing 1-12 of 12

Last Updated: 09/26/2026